Health
Needle-phobes rejoice: NeedleCalm launches in Australia
An innovative piece of medical technology aimed at reducing physi...
Medibank profit rises, CEO Craig Drummond to depart
Private health insurance provider Medibank (ASX: MPL) has capital...
Starpharma's anti-COVID nasal spray approved in Europe and the UK
Australian pharmaceutical company Starpharma's (ASX: SPL) ant...
Record flu vaccine demand gives 44 per cent shot in the arm to CSL earnings
Mitigation measures against COVID-19 led to a drastic reduction i...
Profits double for IVF specialist Virtus Health
As the leading assisted reproductive services (ARS) company ...
Advertisement
Latest News
Needle-phobes rejoice: NeedleCalm launches in Australia
An innovative piece of medical technology aimed at reducing physi...
Facebook versus News: Advertising is the real problem
The fight between Facebook and the Morrison government is over al...
Ardent Leisure expects wild ride to continue all year
Dreamworld operator Ardent Leisure's (ASX: ALG) fortunes cont...
Housing demand, retail recovery boost Stockland's earnings
Demand for residential housing and a recovering retail environmen...
Parliament passes media bargaining code
A media bargaining code, developed to bring a sense of balance to...
Noxopharm study results herald "new era" for prostate cancer treatment
A trial of Noxopharm's (ASX: NOX) prostate cancer treatment h...
What's the difference between mutations, variants and strains? A guide to COVID terminology
Living through a global pandemic over the past year has seen all ...
Mesoblast rises on positive back pain trial results
Positive results from stem cell research company Mesoblast's ...
Eyes and ears on Healthia as shares double in four months
Investors appeared to take little notice of allied health group H...
Little Green Pharma plans $22m raise to boost cannabis production and push internationally
Medicinal cannabis cultivator and manufacturer Little Green Phar...
Why Cynata is hopeful its COVID treatment trial will succeed where others have failed
Cynata Therapeutics (ASX: CYP), founded by two clever stem cell r...
How Smiles Inclusive was turned upside down: A timeline of decay
For retail investors there is something very reassuring about put...
AnteoTech spikes on customer Ellume's $304m US contract news
Shares in Brisbane-based nanotechnology company AnteoTech (ASX: A...
Ellume secures $304m US Government contract to scale up COVID-19 test production
Brisbane-based diagnostics company Ellume has today announced a U...
Tomas Steenackers mimics National Vet Care with new optometry venture
After the ASX-listed company he founded was offered a $251.5 mill...
Little Green Pharma finds French foothold as primary manufacturer for cannabis trial
Medicinal cannabis company Little Green Pharma (ASX: LGP) is toda...
Immutep's EAT COVID trial progresses to the next phase
A trial of biotechnology company Immutep's (ASX: IMM) experim...
AnteoTech's rapid-test success shines light on Brisbane as a COVID tech hub
AnteoTech's (ASX: ADO) plans to bring a rapid COVID-19 test t...
Ecofibre signs "milestone" international distribution deal for CBD products
A new deal between Ecofibre (ASX: EOF) and Sydney-based pharmaceu...
Smiles Inclusive CEO resigns as Genesis Capital wins bid to acquire assets
After 10 months at the helm of embattled Gold Coast-based dental ...
Advertisement
Partner Content
It's fair to say that at the start of 2020, few would have pr...
Momentum for cannabis stocks continues to intensify, as internati...
ESG (Environment, Social, Governance) has become essential in bus...
While some prefer to invest their money in stocks, bonds or prope...
If intellectual property (IP) is what differentiates a business f...
The COVID-19 pandemic has fundamentally changed the way Australia...
Curtin University and Extreme Tech Challenge (XTC) have partnere...
Due diligence is paramount for responsible lending, but that does...
After seeing how expensive and time-consuming it was for the mili...
Upskilling was the name of the game when energy specialist Jessie...
Advertisement